Sigyn Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Sigyn Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q3 2024.
  • Sigyn Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$388K, a 47.8% decline year-over-year.
  • Sigyn Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.23M, a 23.7% increase year-over-year.
  • Sigyn Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.69M, a 116% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$783K, a 21.5% increase from 2021.
  • Sigyn Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$996K, a 190% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.23M -$388K -$126K -47.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$1.11M -$260K -$110K -74.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 -$999K -$128K +$692K +84.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$1.69M -$459K -$71.5K -18.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$1.62M -$263K -$70.1K -36.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$1.55M -$149K -$15.6K -11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 -$1.53M -$820K -$751K -1091% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$783K -$387K +$249K +39.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$1.03M -$193K -$100K -108% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$931K -$134K +$74.5K +35.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.01M -$68.8K -$9.22K -15.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$996K -$636K -$529K -492% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$468K -$92.5K +$472 +0.51% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$468K -$208K -$124K -146% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$345K -$59.6K -$1.38K -2.38% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$343K -$107K +$2.64M +96.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$2.98M -$93K -$77.2K -487% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$2.91M -$84.5K -$69K -445% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.84M -$58.2K -$42.7K -276% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.8M -$2.75M -$1.78M -183% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-30
Q3 2019 -$1.02M -$15.9K +$71.4K +81.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$1.09M -$15.5K -$97K -119% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$991K -$15.5K +$309K +95.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$1.3M -$970K -$693K -250% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$607K -$87.2K +$830K +90.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.44M $81.5K +$434K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$1.87M -$324K -$54.3K -20.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-19
Q4 2017 -$1.82M -$277K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$917K -$814K -790% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$352K -$710K -198% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$270K -$405K -299% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 -$103K Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $358K Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $135K Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.